BIOMARIN PHARMACEUTICAL INC (BMRN) Insider Trading Disclosures
BIOMARIN PHARMACEUTICAL INC (BMRN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BMRN
CIK: 1048477
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJason Trimborn
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001048477-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0001628280-26-064272 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-24 | 8-K | 0001628280-26-063981 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001628280-26-061973 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | FORM 4 | 0001628280-26-061940 | View SEC Doc Filr Page |
| 3 | 2026-09-14 | 2026-09-10 | FORM 3 | 0001628280-26-061934 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-10 | 8-K | 0001628280-26-061717 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001628280-26-060572 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006644 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-31 | 8-K | 0001193125-26-377696 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-30 | 8-K | 0001193125-26-375275 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-17 | 8-K | 0001193125-26-354780 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001193125-26-338468 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001048477-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001048477-26-000015 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-13 | 2026-04-27 | 8-K/A | 0001048477-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040922 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040920 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040918 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040916 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040914 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040911 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040909 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040907 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040903 | View SEC Doc Filr Page |